MedTrace Logo

Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice

NCT02012036 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-08-16

No results posted yet for this study

Summary

The purpose of the study is to assess additional detection of Non-Muscle-Invasive Bladder Cancer (NMIBC) with hexyl aminolevulinate (HAL) cystoscopy based on lesions in patients undergoing TUR-B compared to white-light cystoscopy under the conditions of daily clinical practice.

Conditions

  • Photodynamic Transurethral Resection of the Bladder (TUR-B)

Interventions

DRUG

Hexvix

As this is a non-interventional study, detection of NMIBC with Hexvix is in a pre-defined group, chosen prior to and independently from the decision to enrol the subject in this study. The detection with Hexvix should be in accordance with local Summary of Product Characteristics \[SmPC\]. Subjects will be treated in accordance with usual medical practice during their participation in this study, no additional assessment or tests will be required.

Sponsors & Collaborators

Principal Investigators

  • Ipsen Medical Director · Ipsen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02012036 on ClinicalTrials.gov